Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patrick Emonts is active.

Publication


Featured researches published by Patrick Emonts.


Annals of Oncology | 2012

Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy

Alain Hendlisz; Vassilis Golfinopoulos; Camilo Garcia; A. Covas; Patrick Emonts; Lieveke Ameye; Marianne Paesmans; Amélie Deleporte; G. Machiels; E. Toussaint; Bruno Vanderlinden; Ahmad Awada; Martine Piccart; Patrick Flamen

BACKGROUND The study purpose was to assess the predictive value of 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG)-positron emission tomography (PET)/computerized tomography (CT) metabolic response after a single course of chemotherapy in patients with metastatic colorectal cancer (mCRC). PATIENTS AND METHODS FDG-PET/CT scans were carried out at baseline and on day 14 in 41 patients with unresectable mCRC treated with a biweekly regimen of chemotherapy. Metabolic nonresponse was defined by <15% decrease in FDG uptake in the dominant proportion of the patients lesions or if a lesion was found metabolically progressive. The PET-based response was correlated with radiological response (primary end point) and patients outcome (secondary end points). RESULTS RECIST response rate in metabolically responding patients was 43% (10 of 23) compared with 0% (0 of 17) in nonresponding patients (P=0.002). The metabolic assessments predictive performance for RECIST response was sensitivity 100% [95% confidence interval (CI) 69% to 100%], specificity 57% (95% CI 37% to 75%), positive predictive value 43% (95% CI 23% to 66%), and negative predictive value 100% (95% CI 80% to 100%). Comparing metabolically responding versus nonresponding patients, the hazard ratio (HR) was 0.28 (95% CI 0.10-0.76) for overall survival and 0.57 (95% CI 0.27-1.21) for progression-free survival. CONCLUSION The metabolic response measured by FDG-PET/CT after a single course of chemotherapy in mCRC is able to identify patients who will not benefit from the treatment.


Hypertension in Pregnancy | 2008

Prediction of Maternal Predisposition to Preeclampsia

Patrick Emonts; Sontera Seaksan; Laurence Seidel; H. Thoumsin; Ulysse Gaspard; Adelin Albert; Jean-Michel Foidart

Objective: To derive a prediction index based on the most salient patient history, laboratory, and clinical parameters for identifying women at high risk for developing preeclampsia (PE). Methods: Nonpregnant women with a history of PE (n = 101) were compared with nonpregnant parous women with a history of one or more successful normotensive pregnancies (n = 50) but with comparable age, gestation, and parity profiles. The parameters included a medical examination (demographics, patient history, family history, and clinical and obstetrical findings), laboratory investigations (hemostasis, coagulation, and vitamins), and morphological and functional tests (cardiovascular and renal functions). Stepwise logistic regression analysis was applied to develop a three-step PE prediction index based on the most discriminant parameters. Results: Patients with and without PE differed significantly (p < 0.05) with respect to 1) maternal history of chronic hypertension, body mass index, and blood pressure; 2) APTT, PT, activated factor VIII, homocystein, free protein S and vitamin B1; and 3) relative plasma volume. Based on these three sets of parameters, a three-step PE prediction index was developed. The likelihood ratio of a positive index score was equal to 3.4, 7.3, and 8.8, respectively. Thus, assuming a PE prevalence (or prior probability) of 5%, a patients chances of developing PE when presenting with a positive score on the three-step prediction index were 15%, 28%, and 32%, respectively. Discussion: In the absence of welldefined pre-pregnancy screening guidelines for PE, the present study attempts to proceed in a stepwise fashion by looking at medical examination data first, requesting, if necessary, specific hemostasis and coagulation tests next, and finally measuring the relative plasma volume for confirmatory purposes. This approach offers a satisfactory positive predictive value and cost efficiency ratio.


Current Opinion in Oncology | 2009

Functional imaging of head and neck cancers.

Patrick Emonts; Pierre Bourgeois; Marc Lemort; Patrick Flamen

Purpose of review Functional imaging including single photon emission computed tomography, PET and MRI techniques in head and neck squamous cell cancer allows disease characterization beyond structure and morphology. Recent findings In patients without clinical signs of lymph node involvement, sensitivity of fluoro-2-deoxy-D-glucose PET is only 50%. This has led to the use of sentinel lymph node scintigraphy that seems to be a valid alternative to elective stage dissection. Additionally, the use of single-photon emission computed tomography–computed tomography imaging enables a more accurate localization of the sentinel lymph node scintigraphy. The fluoro-2-deoxy-D-glucose uptake intensity of the head and neck squamous cell carcinoma sites is related to locoregional control and overall survival. In case of suspicion for residual or recurrent head and neck squamous cell carcinoma after surgery or (chemo)radiotherapy, fluoro-2-deoxy-D-glucose-PET has a high sensitivity and seems to be cost-effective in selecting patients for direct laryngoscopy. Diffusion-weighted MRI in combination with size and morphological criteria is a strong predictor of presence of malignant lymph nodes. Initial reports indicate the use of diffusion-weighted imaging for response assessment as early as 1 week after beginning of radiochemotherapy. Perfusion MRI is studied for the measurement of drug effects on tumour (micro)vascularity and capillary permeability. Summary Functional imaging improves the initial staging and the detection of residual or recurrent disease following therapy.


Aging Clinical and Experimental Research | 2016

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

C Cooper; Thomas Bardin; Maria Luisa Brandi; Patrice Cacoub; John Caminis; Roberto Civitelli; Maurizio Cutolo; W. Dere; Jean-Pierre Devogelaer; A Diez-Perez; Thomas A. Einhorn; Patrick Emonts; Olivier Ethgen; John A. Kanis; Jean-Marc Kaufman; Tore K. Kvien; Willem F. Lems; Eugene McCloskey; Pierre Miossec; Susanne Reiter; Johann D. Ringe; René Rizzoli; Kenneth G. Saag; Jean-Yves Reginster

AbstractPurposeThis consensus review article considers the question of whether glucocorticoid (GC) therapy is still relevant in the treatment of rheumatic diseases, with a particular focus on rheumatoid arthritis (RA), and whether its side effects can be adequately managed. Recent basic and clinical research on the molecular, cellular and clinical effects of GCs have considerably advanced our knowledge in this field. An overview of the subject seems appropriate.MethodsThis review is the result of a multidisciplinary expert working group, organised by European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. The recent literature was surveyed and the salient evidence synthetized.ResultsThe pathophysiological basis of RA (and other inflammatory rheumatic diseases) now strongly implicates the adaptive immune system in addition to innate mechanisms. The molecular effect of GCs and differential GC sensitivity is better understood, although exploiting this knowledge is still in its infancy. The newer treatment strategies of early and aggressive control of RA have gr eatly improved clinical outcomes, but improvements are still possible. Newer targeted anti-inflammatory drugs have made an important impact, yet they too are associated with numerous side effects.DiscussionShort durations of moderate doses of GCs are generally well tolerated and have a positive benefit/risk ratio. Patients should be assessed for fracture risk and bone preserving agents and be prescribed calcium and vitamin D supplementation.ConclusionsWithin a strategy of a disease modifying approach to inflammatory disease, combination therapy including a GC is effective approach.


JMIR Research Protocols | 2017

Meeting the Needs of Mothers During the Postpartum Period: Using Co-Creation Workshops to Find Technological Solutions

Justine Slomian; Patrick Emonts; Lara M. Vigneron; Alessandro Acconcia; Jean-Yves Reginster; Mina Oumourgh; Olivier Bruyère

Background The postnatal period is associated with many new needs for mothers. Objective The aim of this study was to find technological solutions that meet the needs of mothers during the year following childbirth. Methods Two co-creation workshops were undertaken with parents and professionals. The aim of the first workshop was to create a list of all the criteria the proposed solution would have to address to meet the needs of mothers after childbirth. The aim of the second workshop was to create solutions in response to the criteria selected during the first workshop. Results Parents and health professionals want solutions that include empathy (ie, to help fight against the feelings of abnormality and loneliness), that help mothers in daily life, that are personalized and adapted to different situations, that are educational, and that assures some continuity in their contact with health professionals. In practice, we found that parents and professionals think the solution should be accessible to everyone and available at all times. To address these criteria, technology experts proposed different solutions, such as a forum dedicated to the postpartum period that is supervised by professionals, a centralized website, a system of videoconferencing, an online exchange group, a “gift voucher” system, a virtual reality app, or a companion robot. Conclusions The human component seems to be very important during the postnatal period. Nevertheless, technology could be a great ally in helping mothers during the postpartum period. Technology can help reliably inform parents and may also give them the right tools to find supportive people. However, these technologies should be tested in clinical trials.


BMC Pregnancy and Childbirth | 2017

Identifying maternal needs following childbirth: A qualitative study among mothers, fathers and professionals

Justine Slomian; Patrick Emonts; Lara M. Vigneron; Alessandro Acconcia; Fabienne Glowacz; Jean-Yves Reginster; Mina Oumourgh; Olivier Bruyère

BackgroundPregnancy and childbirth are two critical stages in a woman’s life. Various studies have suggested that psychological distress is common during the year after childbirth. The objectives of this exploratory study were (1) to explore the needs of mothers in the year following childbirth; (2) to compare these needs between mothers who did not have the feeling of living a psychological disorder or a depression and mothers who lived a psychological disorder or had the impression of living a depression; and (3) to compare the needs expressed by mothers with the perception of professionals and fathers about the mothers’ needs.MethodsFirst, we proceeded to 22 individual qualitative interviews followed by one focus group, with mothers, with and without experience of psychological distress. Then, we conducted 2 focus groups: one with professionals and one with fathers.ResultsNeeds of mothers after childbirth have been indexed in four categories: need of information, need of psychological support, need to share experience, and need of practical and material support. Women do not feel sufficiently informed about this difficult period of life. They do not feel sufficiently supported, not only from a psychological point of view but also from a more practical point of view, for example with household chores. They need to share their experience of life, they need to be reassured and they need to feel understood. It seems that some differences exist between mothers’ and professionals’ experiences but also between mothers’ and fathers’ experiences.ConclusionYoung mothers apparently feel a lack of support at different levels in the year following childbirth. This study provides ways to meet women’s needs and to try to prevent the risk of postpartum psychological distress during this period of time.


Midwifery | 2018

The “Happy-Mums” website dedicated to the perinatal period: Evaluation of its acceptability by parents and professionals

Justine Slomian; Lara M. Vigneron; Patrick Emonts; Jean-Yves Reginster; Olivier Bruyère

OBJECTIVE Pregnancy and childbirth are associated with new needs for mothers, especially an eagerness for information. The aim of this study was to evaluate whether the Happy-Mums.be website meets the expectations and needs of its future users. DESIGN After the development of the Happy-Mums.be website, it was submitted to parents and professionals and evaluated by an online survey, which consisted of the third round of an ongoing Delphi survey. SETTING AND PARTICIPANTS The panel involved in the survey included parents (both mothers and fathers) and professionals (health professionals and early childhood professionals, orbiting mothers of children aged 0-2 years). FINDINGS Twenty-eight parents and professionals participated in the third round of the Delphi survey. The participants indicated that Happy-Mums.be was useful and easy to use. They attributed a mean score of 8 out of 10 for the content, design and quality of the information on the Happy-Mums.be website. The majority of participants said that they would recommend the website both during pregnancy and the postnatal period. CONCLUSIONS Happy-Mums.be meets the needs and expectations of parents and professionals in terms of both content and design. More specifically, the quality of the information found on Happy-Mums.be was judged to be significantly better than the information found on other websites.


Revue des Maladies Respiratoires Actualités | 2014

Apport de l’imagerie médicale conventionnelle dans la prise en charge des cancers bronchiques

Patrick Emonts

For lung cancer staging, both CT scan of the chest with contrast and PET-CT imaging are recommended. Suspected mediastinal/hilar nodes and isolated distant metastasis have to be pathologically confirmed. Despite some radiological patterns, CT appearance has a low specificity in predicting the histological type. Complications and other thoracic pathologies are described on CT scan. Percutaneous biopsies and tumour radio ablations are guided by CT scan. The same imaging modality is used for planning stereotactic radiation therapy, electromagnetic endobronchial navigation and other minimally invasive bronchoscopic airway interventions. Dual energy CT increases contrast and provides a lung perfusion imaging. Iterative reconstructions and dual energy CT together allow for the near future a considerable dose reduction.


Gynecology & Obstetrics | 2014

Persistent Right-Sided Umbilical Vein and Azygos Continuity associated with Ophthalmological and Pulmonary Malformations. Prenatal Diagnosis of an Exceptional Case

Sylvie Lepage; Xavier Capelle; Patrick Emonts; Frédéric Kridelka; Marie-Christine Seghaye; Christine Van Linthout

We report on the case of a fetus in whom a prenatal ultrasound performed at 22 weeks of gestation allowed the diagnosis of a double anomaly of the systemic venous return, with a persistent right umbilical vein and the agenesis of the inferior vena cava with azygos continuity. The fetus showed also a large umbilical hernia and a right sided microphtalmia. Fetal growth was normal. Genetic anomalies were excluded by karyotype and CGH array. Cesarean section was performed at 39 weeks of gestational age for breech presentation. The neonate adapted well. Post-natal examination confirmed pre-natal diagnosis. Thoraco-abdominal CT-scan performed at 8 days of age showed additional right upper lobe bronchial atresia with relative hypoplasia of the right pulmonary artery and right hepatic lobe hypotrophy. It also showed a short segmental infra diaphragmatic aplasia of the vena cava with dilation of the azygos vein running along the homolateral diaphragmatic coupola that drained into superior vena cava and malposition of the mesenterial vessels without any intestinal malrotation. Anomalies of the fetal cardinals and umbilical veins are the result of early abnormal venous system development in the embryo, the etiology of which is unknown. Usually, abnormal systemic venous return only affects one vessel. The presence of a double anomaly as described in this case is exceptional. A persistent right umbilical vein is reported in 0.2 to 0.4% of antenatal screening. The variant with intrahepatic transition is the most frequent and isolated form. The exceptional, form with hepatic bypass, is commonly part of a polymalformative syndrome. Agenesis of the inferior vena cava (IVC) with azygos continuity is a rare anomaly (0,2-3% of antenatal screening). Its significance relates to its frequent association with complex congenital heart diseases. The prognosis of anomalies of cardinals and umbilical veins depends on the presence of associated cardiac and extra cardiac malformations that might impact prenatal counseling and parental decision to continue or interrupt pregnancy. Careful repeated pre and post-natal evaluation is necessary to exclude polymalformative syndrome despite of normal molecular genetic examination.


Journal of Clinical Oncology | 2011

Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy

Alain Hendlisz; Vassilis Golfinopoulos; Camilo Garcia; Patrick Emonts; A. Covas; Lieveke Ameye; Marianne Paesmans; Amélie Deleporte; G. Machiels; E. Toussaint; Bruno Vanderlinden; Ahmad Awada; Martine Piccart; Patrick Flamen

3593 Background: The purpose of our study was to assess the predictive value of FDG-PET/CT metabolic response after a single course of chemotherapy in patients with metastatic colorectal cancer (mCRC). METHODS We performed two FDG-PET/CT scans (at baseline and on day 14) in 41 patients with unresectable mCRC treated with a biweekly regimen of chemotherapy. Patients were classified as metabolically non-responders when the dominant proportion of the tumor load showed a decrease in FDG uptake less than 15%, or if at least one lesion was demonstrated to be metabolically progressive. The PET-based response was correlated with RECIST-based response (primary endpoint), and progression-free and overall survival (secondary endpoints). RESULTS RECIST response rate in metabolically responding patients was 43% (10/23) compared to 0% (0/17) in metabolically non-responding patients (P=0.002). The predictive performance of the metabolic assessment for RECIST response was sensitivity 100% (95% CI, 69% to 100%), specificity 57% (95% CI, 37% to 75%), positive predictive value 43% (95% CI, 23% to 66%) and negative predictive value 100% (95% CI, 80% to 100%). Comparing metabolically responding versus non-responding patients, the hazard ratio was 0.28 (95% CI, 0.10 to 0.76, P=0.008) for overall survival and 0.57 (95% CI, 0.27 to 1.21, P=0.14) for progression-free survival. CONCLUSIONS The metabolic response measured by FDG-PET/CT after a single course of chemotherapy in mCRC is able to identify the patients who will not benefit from the treatment.

Collaboration


Dive into the Patrick Emonts's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marc Lemort

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Patrick Flamen

Université libre de Bruxelles

View shared research outputs
Researchain Logo
Decentralizing Knowledge